Free Trial
→ One executive order. The biggest wealth transfer of your lifetime. (From Reagan Gold Group) (Ad)tc pixel Free CMPS Stock Alerts

Compass Pathways (CMPS) Financials

Compass Pathways logo
$9.76 +0.44 (+4.72%)
Closing price 04:00 PM Eastern
Extended Trading
$9.76 0.00 (-0.05%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Compass Pathways

Annual Income Statements for Compass Pathways

This table shows Compass Pathways' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -20 -60 -72 -92 -118 -155 -288
Consolidated Net Income / (Loss)		 -20 -60 -72 -92 -118 -155 -288
Net Income / (Loss) Continuing Operations		 -20 -60 -72 -92 -118 -155 -288
Total Pre-Tax Income 		-20 -60 -72 -91 -118 -154 -290
Total Operating Income		 -21 -51 -83 -110 -137 -178 -179
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 21 51 83 110 137 178 179
Selling, General & Admin Expense		 8.62 28 39 45 49 59 61
Research & Development Expense		 13 23 44 65 88 119 118
Total Other Income / (Expense), net		 1.58 -8.91 12 19 19 25 -111
Interest Expense		 - - 0.00 0.00 2.20 4.48 4.52
Interest & Investment Income		 - - - - 4.62 8.27 7.18
Other Income / (Expense), net		 1.58 -8.91 12 19 17 21 -114
Income Tax Expense		 0.02 0.03 0.20 0.41 0.78 1.59 -2.47
Basic Earnings per Share		 ($2.62) ($3.55) ($1.79) ($2.16) ($2.32) ($2.30) ($3.08)
Weighted Average Basic Shares Outstanding		 7.48M 16.99M 40.00M 42.44M 51.03M 67.48M 93.50M
Diluted Earnings per Share		 ($2.62) ($3.55) ($1.79) ($2.16) ($2.32) ($2.30) ($3.08)
Weighted Average Diluted Shares Outstanding		 7.48M 16.99M 40.00M 42.44M 51.03M 67.48M 93.50M
Weighted Average Basic & Diluted Shares Outstanding		 7.48M 16.99M 42.02M 42.76M 64.23M 92.67M 128.92M

Quarterly Income Statements for Compass Pathways

This table shows Compass Pathways' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -28 -34 -33 -35 -38 -39 -44 -18 -38 -138 -94
Consolidated Net Income / (Loss)		 -28 -33 -33 -35 -38 -39 -43 -18 -38 -138 -94
Net Income / (Loss) Continuing Operations		 -28 -33 -33 -35 -38 -39 -43 -18 -38 -138 -94
Total Pre-Tax Income 		-28 -33 -32 -35 -38 -38 -42 -18 -38 -138 -97
Total Operating Income		 -33 -34 -38 -39 -43 -48 -48 -50 -43 -41 -46
Total Operating Expenses		 33 34 38 39 43 48 48 50 43 41 46
Selling, General & Admin Expense		 13 13 11 14 14 15 16 19 13 13 16
Research & Development Expense		 20 22 27 25 29 33 32 31 30 27 30
Total Other Income / (Expense), net		 4.52 0.74 6.27 3.61 5.40 9.57 6.11 32 4.67 -97 -51
Interest Expense		 0.00 1.08 1.12 1.10 1.11 1.14 1.13 1.12 1.15 1.11 1.14
Interest & Investment Income		 0.64 1.02 - 2.26 2.41 1.98 - 2.39 1.90 1.59 1.31
Other Income / (Expense), net		 3.89 0.80 4.42 2.45 4.10 8.73 3.35 31 3.92 -98 -51
Income Tax Expense		 0.19 0.06 0.39 0.22 0.18 0.17 1.02 0.35 0.14 -0.23 -2.73
Basic Earnings per Share		 ($620.00) ($0.67) $618.92 ($0.55) ($0.56) ($0.56) $558.81 ($0.20) ($0.41) ($1.44) ($1.03)
Weighted Average Basic Shares Outstanding		 45.57M 49.63M 51.03M 64.22M 68.37M 68.40M 67.48M 89.19M 93.34M 95.34M 93.50M
Diluted Earnings per Share		 ($620.00) ($0.67) $618.92 ($0.55) ($0.56) ($0.56) $558.81 ($0.24) ($0.41) ($1.44) ($0.99)
Weighted Average Diluted Shares Outstanding		 45.57M 49.63M 51.03M 64.22M 68.37M 68.40M 67.48M 98.64M 93.34M 95.34M 93.50M
Weighted Average Basic & Diluted Shares Outstanding		 45.78M 61.90M 64.23M 68.38M 68.39M 68.42M 92.67M 93.56M 95.94M 96.02M 128.92M

Annual Cash Flow Statements for Compass Pathways

This table details how cash moves in and out of Compass Pathways' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 2.08 165 83 -130 77 -55 -15
Net Cash From Operating Activities		 -18 -41 -68 -105 -97 -119 -157
Net Cash From Continuing Operating Activities		 -18 -41 -68 -105 -97 -119 -157
Net Income / (Loss) Continuing Operations		 -20 -60 -72 -92 -118 -155 -288
Consolidated Net Income / (Loss)		 -20 -60 -72 -92 -118 -155 -288
Depreciation Expense		 0.06 0.11 0.18 0.33 0.24 0.23 0.22
Amortization Expense		 - 0.00 1.80 2.13 0.64 3.71 3.88
Non-Cash Adjustments To Reconcile Net Income		 4.39 20 8.66 14 17 20 141
Changes in Operating Assets and Liabilities, net		 -2.66 -0.91 -6.64 -31 3.48 12 -14
Net Cash From Investing Activities		 -0.17 -0.63 -0.33 -0.60 -0.06 0.00 0.00
Net Cash From Continuing Investing Activities		 -0.17 -0.63 -0.33 -0.60 -0.06 0.00 0.00
Net Cash From Financing Activities		 18 194 157 1.04 174 64 141
Net Cash From Continuing Financing Activities		 18 194 157 1.04 174 64 141
Issuance of Common Equity		 0.00 133 155 0.64 145 27 141
Other Financing Activities, net		 0.00 0.02 1.85 0.40 -0.26 37 0.04
Effect of Exchange Rate Changes		 1.68 13 -5.58 -25 0.87 0.19 1.05
Cash Interest Paid		 - - 0.00 0.00 1.25 3.07 3.05
Cash Income Taxes Paid		 - - - - 2.44 1.12 0.76

Quarterly Cash Flow Statements for Compass Pathways

This table details how cash moves in and out of Compass Pathways' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents		 31 100 -28 43 -34 -22 -42 95 -38 -36 -36
Net Cash From Operating Activities		 -25 -17 -28 -21 -34 -22 -42 -46 -39 -35 -38
Net Cash From Continuing Operating Activities		 -25 -17 -28 -21 -34 -22 -42 -46 -39 -35 -38
Net Income / (Loss) Continuing Operations		 -28 -33 -33 -35 -38 -39 -43 -18 -38 -138 -94
Consolidated Net Income / (Loss)		 -28 -33 -33 -35 -38 -39 -43 -18 -38 -138 -94
Depreciation Expense		 0.11 0.19 -0.10 0.06 0.06 0.06 0.05 0.04 0.16 0.02 0.01
Amortization Expense		 -0.54 0.31 0.33 0.89 0.89 0.95 2.67 0.38 1.56 0.28 1.66
Non-Cash Adjustments To Reconcile Net Income		 5.48 5.35 3.93 5.36 5.05 3.82 4.36 -11 5.08 106 41
Changes in Operating Assets and Liabilities, net		 -1.53 10 0.59 8.05 -2.32 11 -5.51 -18 -7.09 -3.41 14
Net Cash From Financing Activities		 56 117 0.04 64 0.21 -0.05 0.16 140 0.17 - 0.19
Net Cash From Continuing Financing Activities		 56 117 0.04 64 0.21 -0.05 0.16 140 0.17 - 0.19
Issuance of Common Equity		 27 117 0.12 26 0.21 - 0.16 140 0.16 - 0.16
Other Financing Activities, net		 0.00 -0.08 -0.08 37 - -0.05 - 0.00 0.01 - 0.02
Effect of Exchange Rate Changes		 0.01 0.18 0.01 -0.05 -0.05 0.56 -0.27 0.32 0.29 -0.84 1.27

Annual Balance Sheets for Compass Pathways

This table presents Compass Pathways' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 32 203 301 197 276 214 210
Total Current Assets		 32 202 295 192 261 201 191
Cash & Equivalents		 25 190 273 143 220 165 150
Restricted Cash		 0.02 0.03 0.10 0.18 0.44 0.39 0.38
Prepaid Expenses		 7.19 12 22 48 41 36 42
Plant, Property, & Equipment, net		 0.22 0.25 0.40 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.00 0.28 5.20 5.64 15 12 19
Noncurrent Deferred & Refundable Income Taxes		 0.00 0.22 0.77 2.22 3.34 3.77 3.75
Other Noncurrent Operating Assets		 0.00 0.06 4.43 3.42 11 8.60 15
Total Liabilities & Shareholders' Equity		 32 203 301 197 276 214 210
Total Liabilities		 24 6.90 16 16 50 59 263
Total Current Liabilities		 24 6.90 15 16 20 34 248
Short-Term Debt		 21 - - - 0.00 5.51 18
Accounts Payable		 2.78 6.90 13 14 17 27 24
Other Current Liabilities		 - 0.00 2.24 1.51 2.41 1.73 206
Total Noncurrent Liabilities		 0.00 0.00 1.38 0.42 31 25 15
Long-Term Debt		 - - - 0.00 29 25 14
Other Noncurrent Operating Liabilities		 - 0.00 1.38 0.42 1.88 0.30 1.29
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -30 197 284 181 226 155 -53
Total Preferred & Common Equity		 -30 197 284 181 226 155 -53
Total Common Equity		 -30 197 284 181 225 155 -53
Common Stock		 7.27 280 445 459 622 706 785
Retained Earnings		 -38 -98 -170 -261 -380 -535 -823
Accumulated Other Comprehensive Income / (Loss)		 -0.10 15 8.84 -17 -17 -16 -15

Quarterly Balance Sheets for Compass Pathways

This table presents Compass Pathways' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 210 299 309 279 247 319 294 256
Total Current Assets		 194 285 296 265 234 305 276 242
Cash & Equivalents		 148 248 263 229 207 260 222 186
Restricted Cash		 0.25 0.33 0.39 0.39 0.39 0.38 0.38 0.38
Prepaid Expenses		 45 36 31 36 26 45 54 56
Plant, Property, & Equipment, net		 0.48 0.31 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 16 14 13 13 14 14 17 13
Noncurrent Deferred & Refundable Income Taxes		 3.05 3.41 3.66 4.02 4.41 4.03 4.29 4.53
Other Noncurrent Operating Assets		 13 11 9.82 9.42 9.26 9.64 13 8.69
Total Liabilities & Shareholders' Equity		 210 299 309 279 247 319 294 256
Total Liabilities		 43 46 50 52 54 124 131 218
Total Current Liabilities		 13 15 19 22 26 30 31 197
Short-Term Debt		 - - - - 2.16 8.99 7.98 13
Accounts Payable		 11 13 17 20 22 20 21 17
Other Current Liabilities		 2.18 2.10 2.38 2.39 2.30 1.23 2.05 168
Total Noncurrent Liabilities		 31 30 30 30 28 94 100 21
Long-Term Debt		 28 28 29 29 28 22 23 19
Other Noncurrent Operating Liabilities		 2.54 2.00 1.34 0.80 0.46 72 77 1.97
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 166 253 259 226 193 195 163 38
Total Preferred & Common Equity		 166 253 259 226 193 195 163 38
Total Common Equity		 166 253 259 226 193 195 163 38
Common Stock		 497 618 691 696 701 764 768 781
Retained Earnings		 -314 -347 -415 -453 -491 -553 -591 -729
Accumulated Other Comprehensive Income / (Loss)		 -17 -17 -17 -17 -17 -16 -15 -15

Annual Metrics And Ratios for Compass Pathways

This table displays calculated financial ratios and metrics derived from Compass Pathways' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 35,930,331.00 35,930,331.00 42,522,397.00 61,896,535.00 - 96,017,044.00
DEI Adjusted Shares Outstanding		 0.00 35,930,331.00 35,930,331.00 42,522,397.00 61,896,535.00 - 96,017,044.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -1.68 -2.00 -2.15 -1.91 - -3.00
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -15 -36 -58 -77 -96 -125 -125
Return On Investment Capital (ROIC_SIMPLE)		 - - - - -37.66% -67.48% 590.74%
Earnings before Interest and Taxes (EBIT)		 -20 -60 -72 -91 -120 -157 -293
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -20 -60 -70 -89 -119 -153 -289
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -37 -64 -104 -92 -110 65
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 4.62 5.68 11 38 34 19 -171
Increase / (Decrease) in Invested Capital		 0.00 1.05 5.39 27 -4.04 -14 -191
Book Value per Share		 ($4.06) $11.57 $7.92 $4.27 $3.64 $2.26 ($0.55)
Tangible Book Value per Share		 ($4.06) $11.57 $7.92 $4.27 $3.64 $2.26 ($0.55)
Total Capital		 30 197 284 181 255 185 -21
Total Debt		 21 0.00 0.00 0.00 29 30 32
Total Long-Term Debt		 0.00 0.00 0.00 0.00 29 25 14
Net Debt		 -3.90 -190 -273 -143 -192 -135 -118
Capital Expenditures (CapEx)		 0.17 0.13 0.33 0.60 0.06 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.41 5.15 6.85 33 21 7.32 -189
Debt-free Net Working Capital (DFNWC)		 29 196 280 176 242 173 -39
Net Working Capital (NWC)		 8.30 196 280 176 242 167 -56
Net Nonoperating Expense (NNE)		 4.79 24 13 14 23 30 163
Net Nonoperating Obligations (NNO)		 -3.90 -191 -273 -143 -192 -135 -118
Total Depreciation and Amortization (D&A)		 0.06 0.11 1.97 2.46 0.88 3.94 4.09
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($3.55) ($1.79) ($2.16) ($2.32) ($2.30) ($3.08)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 35.93M 40.00M 42.44M 51.03M 67.48M 93.50M
Adjusted Diluted Earnings per Share		 $0.00 ($3.55) ($1.79) ($2.16) ($2.32) ($2.30) ($3.08)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 35.93M 40.00M 42.44M 51.03M 67.48M 93.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($3.55) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 16.99M 42.02M 42.76M 64.23M 92.67M 128.92M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -36 -58 -77 -96 -125 -125
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for Compass Pathways

This table displays calculated financial ratios and metrics derived from Compass Pathways' official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding		 45,621,678.00 45,783,171.00 61,896,535.00 64,227,371.00 68,380,857.00 68,388,194.00 - 92,673,132.00 93,561,753.00 95,941,264.00 96,017,044.00
DEI Adjusted Shares Outstanding		 45,621,678.00 45,783,171.00 61,896,535.00 64,227,371.00 68,380,857.00 68,388,194.00 - 92,673,132.00 93,561,753.00 95,941,264.00 96,017,044.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.61 -0.75 -0.53 -0.55 -0.56 -0.56 - -0.19 -0.41 -1.44 -0.98
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -23 -24 -27 -27 -30 -34 -34 -35 -30 -28 -32
Return On Investment Capital (ROIC_SIMPLE)		 - - -10.56% -9.37% -11.86% -15.05% -18.33% -15.37% -15.53% -41.21% 151.62%
Earnings before Interest and Taxes (EBIT)		 -29 -33 -34 -36 -39 -39 -45 -19 -39 -138 -97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -29 -33 -34 -35 -38 -38 -42 -18 -37 -138 -95
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -52 -57 -23 -7.71 -11 -16 -19 25 25 105 158
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 46 33 34 25 27 15 19 -34 -29 -117 -171
Increase / (Decrease) in Invested Capital		 29 33 -4.04 -19 -19 -18 -14 -59 -55 -133 -191
Book Value per Share		 $3.65 $5.53 $3.64 $4.04 $3.31 $2.82 $2.26 $2.11 $1.74 $0.39 ($0.55)
Tangible Book Value per Share		 $3.65 $5.53 $3.64 $4.04 $3.31 $2.82 $2.26 $2.11 $1.74 $0.39 ($0.55)
Total Capital		 195 282 255 288 256 223 185 226 193 69 -21
Total Debt		 28 28 29 29 29 30 30 31 31 31 32
Total Long-Term Debt		 28 28 29 29 29 28 25 22 23 19 14
Net Debt		 -120 -220 -192 -234 -200 -178 -135 -230 -191 -155 -118
Capital Expenditures (CapEx)		 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 32 21 21 13 14 2.26 7.32 24 31 -129 -189
Debt-free Net Working Capital (DFNWC)		 181 269 242 276 243 210 173 284 253 58 -39
Net Working Capital (NWC)		 181 269 242 276 243 207 167 275 245 45 -56
Net Nonoperating Expense (NNE)		 5.47 9.55 5.65 8.19 7.78 4.97 9.44 -17 8.35 109 62
Net Nonoperating Obligations (NNO)		 -120 -220 -192 -234 -200 -178 -135 -230 -191 -155 -118
Total Depreciation and Amortization (D&A)		 -0.43 0.50 0.22 0.95 0.95 1.00 2.72 0.41 1.72 0.30 1.67
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.62) ($0.67) $618.92 ($0.55) ($560.00) ($0.56) $558.81 ($0.20) ($0.41) ($1.44) ($1.03)
Adjusted Weighted Average Basic Shares Outstanding		 45.57M 49.63M 51.03M 64.22M 68.37M 68.40M 67.48M 89.19M 93.34M 95.34M 93.50M
Adjusted Diluted Earnings per Share		 ($0.62) ($0.67) $618.92 ($0.55) ($560.00) ($0.56) $558.81 ($0.24) ($0.41) ($1.44) ($0.99)
Adjusted Weighted Average Diluted Shares Outstanding		 45.57M 49.63M 51.03M 64.22M 68.37M 68.40M 67.48M 98.64M 93.34M 95.34M 93.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 45.78M 61.90M 64.23M 68.38M 68.39M 68.42M 92.67M 93.56M 95.94M 96.02M 128.92M
Normalized Net Operating Profit after Tax (NOPAT)		 -23 -24 -27 -27 -30 -34 -34 -35 -30 -28 -32
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Compass Pathways (CMPS) continues to operate in a pre-revenue, development-heavy phase. The quarterly data show large research and development and SG&A expenses with ongoing net losses, while cash flow has been heavily influenced by equity financings. The company has maintained sizable cash balances through 2025, primarily driven by equity issuances, which provides a liquidity runway to fund its clinical and development programs.

  • Big equity financing in Q1 2025 provided a major liquidity boost: Issuance of Common Equity about $140.36 million; Net Cash From Continuing Financing Activities about $140.36 million; Net Change in Cash roughly +$95.02 million.
  • Robust cash balance in early 2025: Cash & Equivalents of approximately $260.11 million at the end of Q1 2025, signaling substantial liquidity.
  • Sizable asset base supports ongoing activity: Total assets around $319.14 million in Q1 2025, with a continued large asset base in subsequent quarters (e.g., ~$255.6 million by Q3 2025).
  • Equity base growth via common stock issuance: Total Common Equity around $195.47 million in Q1 2025, reflecting ongoing capital-raising activity to support operations.
  • No revenue yet in these periods: Total Revenue remains effectively zero in several quarters, consistent with a pre-revenue clinical development company.
  • Ongoing high research and development and SG&A expenses: R&D and SG&A remain elevated (e.g., Q4 2025 R&D $29.91M; SG&A $16.05M; Q3 2025 R&D $27.33M; SG&A $13.21M), which is typical for a late-stage development pipeline but weighs on near-term profitability.
  • Persistent quarterly net losses: Net Income / Loss attributable to common shareholders: Q4 2025 around -$93.88M; Q3 2025 around -$137.72M; Q2 2025 around -$38.40M; Q1 2025 around -$17.86M.
  • Operating cash burn persists: Net cash from continuing operating activities is negative in each of these quarters (e.g., Q4 2025 -$37.79M; Q3 2025 -$35.11M; Q2 2025 -$38.69M; Q1 2025 -$45.66M), highlighting ongoing cash burn despite financing gains.
  • Share dilution and negative earnings per share: Weighted average basic & diluted shares outstanding rise (e.g., Q4 2025 ~128.92M); Basic EPS -$1.03 and Diluted EPS -$0.99 in Q4 2025, reflecting dilution alongside ongoing losses.
  • Liabilities at a meaningful level relative to assets: In Q3 2025, Total Liabilities about $218.02M vs. Total Assets $255.61M, indicating a notable leverage burden as the company funds development activities.
05/06/26 10:19 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Compass Pathways' Financials

When does Compass Pathways' fiscal year end?

According to the most recent income statement we have on file, Compass Pathways' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Compass Pathways' net income changed over the last 6 years?

Compass Pathways' net income appears to be on an upward trend, with a most recent value of -$287.86 million in 2025, rising from -$19.61 million in 2019. The previous period was -$155.12 million in 2024. Find out what analysts predict for Compass Pathways in the coming months.

What is Compass Pathways' operating income?
Compass Pathways' total operating income in 2025 was -$179.04 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $179.04 million
How has Compass Pathways' revenue changed over the last 6 years?

Over the last 6 years, Compass Pathways' total revenue changed from $0.00 in 2019 to $0.00 in 2025, a change of 0.0%.

How much debt does Compass Pathways have?

Compass Pathways' total liabilities were at $263.20 million at the end of 2025, a 346.3% increase from 2024, and a 1,002.6% increase since 2019.

How much cash does Compass Pathways have?

In the past 6 years, Compass Pathways' cash and equivalents has ranged from $24.97 million in 2019 to $273.24 million in 2021, and is currently $149.61 million as of their latest financial filing in 2025.

How has Compass Pathways' book value per share changed over the last 6 years?

Over the last 6 years, Compass Pathways' book value per share changed from -4.06 in 2019 to -0.55 in 2025, a change of -86.5%.


Related Companies

Financial statements for NASDAQ:CMPS last updated on 4/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...
Behind the Markets | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely, LLC | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Nobody's Asking Where The SpaceX Money Comes From
When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...
Americas Gold Company | Sponsoredtc pixel
Gold surged 600 dollars last time this indicator peaked
The Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...
Porter & Company | Sponsoredtc pixel